TSH BIOPHARM CORPORATION LTD.
Update：2026/07/14
Industries
Main Industry
Health Care
Main Product/Service
Prescription medication -
1. Cardiovascular
2. Central Nervous
3. Gastrointestinal
4. Others
1. AlphaLiquid® Detect
2. AlphaLiquid®
3. AlphaLiquid®
4. AlphaSolid®
5. Lung Cancer Panel
6. UNITED™
7. Prosigna®
1. Cardiovascular
2. Central Nervous
3. Gastrointestinal
4. Others
1. AlphaLiquid® Detect
2. AlphaLiquid®
3. AlphaLiquid®
4. AlphaSolid®
5. Lung Cancer Panel
6. UNITED™
7. Prosigna®
Founded Year
2010
Unified Business No.
53093421
Status
Active
Number of Employees
0
Total Paid-in
Capital
383,981,400 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
OTC listing(2012)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Dongshenghua is committed to the development of cardiovascular and autoimmune diseases with economic benefits and high barriers, and to provide comprehensive testing services for human genetic testing, liquid cell and genetic testing of cancer patients.
